Cell, Gene

Cell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing - Credence Research

Veröffentlicht: 20.03.2026 um 03:06 Uhr, prnewswire.co.uk

Credence Research Inc. United States of America United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/cell-and-gene-therapy-manufacturing-market-to-reach-usd-146-2-billion-by-2032-amid-rising-demand-for-personalized-therapies-viral-vector-capacity-and-automated-bioprocessing--credence-research-302708581.html

en | CA7609751028 | CELL | boerse | 68923906 |